Back to blog
|Nelson Marques, MS, RD, LD

Creatine Kinase Interpretation in Athletes: Why the Standard Lab Reference Range Misreads Post-Training CK, the Rhabdomyolysis Differential the Sports RD Must Own, and the Weekly-Trending Protocol That Beats a Single Draw

A 24-year-old collegiate rowing coxswain-turned-CrossFit competitor walks into intake with a lab printout that flagged her serum creatine kinase at 4,820 U/L six days after an unaccustomed 40-minute AMRAP that hit her posterior chain hard. Her primary-care nurse practitioner called her to say she was 'in acute kidney failure territory' and told her to go to the emergency department. She went, spent nine hours in observation getting a saline drip and repeat labs, was discharged on 'no exercise for two weeks,' and lost her spot in the qualifier that Saturday. Her second CK draw at the ED — 22 hours after the first — had already dropped to 2,150 U/L. Her creatinine was 0.8 mg/dL throughout. Her urine dipstick was clear for myoglobin. She was, on any reasonable read, a healthy athlete inside a normal post-eccentric CK excursion, misidentified as an incipient rhabdomyolysis on the strength of a single draw compared against a sedentary reference range. The standard laboratory CK reference — usually cited as 30-200 U/L for females and 55-370 U/L for males — was calibrated on adults who did not train. A single post-heavy-training CK draw in an athlete without the ascending-CK, symptom, urine, and renal context tells you almost nothing about muscle injury and much less about kidney risk. Here is the structured CK workup the sports RD should run when a CK value surfaces in the intake or a mid-camp panel: the exercise-induced CK curve, the ULN reset against the athlete population, the rhabdomyolysis-versus-normal-adaptation differential, the weekly-trending protocol that replaces the single-draw misread, the co-management triggers to the sports-medicine physician, and the SOAP pattern that documents the clearance defensibly.

ClinicalBloodworkCreatine KinaseRhabdomyolysisRD Practice

A 24-year-old competitive CrossFit athlete presents to intake six days after an unaccustomed benchmark AMRAP that stacked 40 minutes of thrusters, box step-ups, and rope climbs. Her primary-care nurse practitioner ran a basic metabolic panel plus CK on day two after she called in complaining of quadriceps and low-back soreness that made stairs difficult. Serum CK came back at 4,820 U/L against a lab reference range of 30-200 U/L. The nurse practitioner called her the same afternoon, told her she was 'in rhabdo territory,' and instructed her to go to the emergency department immediately. In the ED she got two liters of normal saline, a urinalysis (myoglobin negative, no red-cell casts), and a repeat CK 22 hours later that came back at 2,150 U/L. Her serum creatinine was 0.8 mg/dL on both draws. Her potassium, phosphorus, calcium, and uric acid were unremarkable. She was discharged with instructions of 'no exercise for two weeks and follow up with your PCP' and lost her Saturday qualifier. She is in the office because she is trying to figure out what happened, whether she has a real underlying problem, and how to structure the next four weeks of training so the same misclassification does not knock her out of the season.

The CK workup that produced her ED visit was the wrong instrument for her presentation. The reference range printed on her lab report — 30-200 U/L — was derived from a sedentary adult population and describes a body that has not moved eccentrically against load in the 72 hours before the draw. A CK of 4,820 U/L in that population is a five-alarm value that reasonably prompts a rhabdomyolysis workup. The same 4,820 U/L in an unaccustomed CrossFit athlete on day two after a novel eccentric-heavy session is inside the expected exercise-induced CK excursion for that stimulus and, in the absence of tea-colored urine, myoglobinuria, potassium and phosphorus derangement, or a rising creatinine, is not exertional rhabdomyolysis. It is normal muscle-membrane leak from a mechanically demanding session that the reference range was never built to characterize. The sports RD who reads that CK the same way the nurse practitioner did will hand off athletes into ED visits, disqualifications, and detraining that the physiology does not warrant — and, more dangerously, will fail to catch the small subset of athletes whose ascending CK trajectory, symptom cluster, and renal signals do warrant escalation. Both misreads run through the same source: the single-draw CK compared against the wrong denominator.

What CK Actually Measures and Why Exercise Moves It

Creatine kinase is a cytoplasmic enzyme that catalyzes the reversible transfer of a phosphate group between ATP and creatine to regenerate ATP from ADP inside cells with high and variable energy demand. Three isoenzymes matter. CK-MM is the skeletal-muscle isoform and accounts for roughly 96-99% of the total CK reported on a standard serum draw in a healthy adult. CK-MB is the cardiac isoform, quantitatively small in most healthy people, and clinically relevant when the total CK rise needs to be disambiguated between skeletal-muscle and myocardial sources. CK-BB is the brain isoform, negligible in serum outside acute central nervous system injury. The 'CK' on a routine chem panel is the total activity across all three isoforms; in an athlete without chest pain, symptoms of myocardial ischemia, or a neurologic event, the elevated total CK is almost always CK-MM from skeletal muscle. Fractionation is not required to make that call.

Skeletal muscle releases CK into the circulation when the muscle-cell membrane is disrupted enough to permit cytoplasmic contents to leak out. Eccentric contraction — where the muscle lengthens under load — produces more mechanical membrane disruption than concentric or isometric work at the same absolute force. Eccentric-heavy sessions therefore produce larger post-session CK excursions than pure-concentric sessions of comparable perceived effort. The CK excursion follows a predictable time course after a demanding session in a trained individual: a modest rise at 24 hours, a peak somewhere between 24 and 72 hours depending on the athlete, the session, and the training history, then a decline back toward baseline over four to seven days. The peak is later and higher when the athlete is unaccustomed to the movement pattern, when the eccentric load is high relative to previous exposure, and when the total volume was substantially above the athlete's habitual load. In accustomed athletes the peak is smaller and earlier and the return to baseline is faster — the 'repeated-bout effect' the muscle-physiology literature has described for four decades.

The absolute magnitude of the exercise-induced CK peak is where the reference-range problem lives. A single hard eccentric session in an unaccustomed but healthy adult routinely peaks CK in the 1,000-10,000 U/L range without any renal insult and without any symptom that warrants escalation. A brutally novel session — an ultramarathon, an unaccustomed CrossFit AMRAP, a return-from-detraining heavy leg day — can peak CK in the 10,000-40,000 U/L range and still resolve on its own in a healthy athlete with intact hydration and renal function. Elite eccentric-heavy training studies have reported peak CKs in the 20,000-50,000 U/L range in accustomed subjects without clinical rhabdomyolysis. The lab reference range of 30-200 or 55-370 U/L does not describe any of these people. The sports RD who reads a CK printout without adjusting the denominator to the athlete's training state, movement history, and time-since-session is guaranteed to misclassify normal muscle-membrane leak as pathology.

The Athlete-Adjusted Reference Frame

The functional upper limit of normal for CK in a training athlete is not a single number. It is a moving target that depends on time-since-session, the eccentric loading of the session, the athlete's training age at that movement pattern, and the direction the value is heading on a repeat draw. The sports RD needs to hold four calibration anchors instead of a single ULN.

First, a resting CK — drawn at least 72 hours after any strenuous eccentric-heavy session — will usually sit in a training athlete somewhere between the lab ULN and roughly 2-3 times the lab ULN, depending on the athlete's chronic training load. A well-trained endurance athlete with a moderate strength program often carries a resting CK in the 200-500 U/L range without any concurrent training insult. A heavy-lifting strength athlete or CrossFit competitor with continuous eccentric exposure often carries a resting CK in the 300-1,000 U/L range. These are not pathologic and do not warrant a workup on their own.

Second, a CK drawn 12-48 hours after a demanding session — the acute-window draw — can reach the 1,000-10,000 U/L range in an accustomed athlete and the 5,000-40,000 U/L range in an athlete who did something novel. The absolute value at this window is dominated by what the athlete did and how well the muscle was habituated to it, not by disease. A 4,820 U/L draw two days after an unaccustomed CrossFit AMRAP in a previously untrained-to-that-stimulus 24-year-old is inside the expected distribution.

Third, the trajectory matters more than the peak. A single elevated draw with no follow-up value is uninterpretable. The clinically meaningful pattern is whether the CK is rising, plateaued, or falling on serial draws 12-24 hours apart. A rising CK past 48-72 hours post-session, or a CK that plateaus at very high values instead of turning downward, is the signal that raises the workup priority. A CK that has clearly turned downward on the second draw, in an athlete who is clinically well, is following the normal exercise recovery curve.

Fourth, the CK value has to be read against renal function, urine appearance, potassium, phosphorus, calcium, uric acid, and the athlete's symptom cluster — not on its own. An isolated CK, however dramatic, is not a diagnosis. A CK read together with a rising creatinine, tea-colored urine, hyperkalemia, hyperphosphatemia, hyperuricemia, hypocalcemia, and severe out-of-proportion muscle pain that does not track the session load is a very different picture. The panel matters. The single CK does not.

The Rhabdomyolysis Differential

Exertional rhabdomyolysis is the clinical syndrome in which enough skeletal-muscle breakdown occurs during or after exercise to spill myoglobin, potassium, and phosphorus into the circulation at a rate the kidney cannot clear safely, producing acute kidney injury, electrolyte derangement, and — in severe cases — cardiac arrhythmia, compartment syndrome, or disseminated intravascular coagulation. It is a real entity, it does happen in athletes, and it is the reason CK gets checked in the first place. The sports RD's job is not to argue that rhabdo does not exist. The job is to know the diagnostic criteria that separate rhabdo from an exercise-induced CK excursion so the workup escalates only when it should.

The current consensus criteria for exertional rhabdomyolysis require three elements: a CK elevation typically defined as at least five times the upper limit of the reference range (so >1,000-1,500 U/L on most reports, though many working definitions use >5,000 U/L to filter out normal exercise excursions), a clinical picture consistent with muscle breakdown (severe muscle pain and swelling out of proportion to the session, weakness, and either myoglobinuria producing tea-colored urine or a positive urine-dipstick heme test in the absence of red blood cells on microscopy), and evidence of end-organ effect (acute kidney injury with a rising serum creatinine, hyperkalemia, hyperphosphatemia, hyperuricemia, hypocalcemia, or metabolic acidosis). A CK of 4,820 U/L, on its own, does not meet criteria. A CK of 4,820 U/L with tea-colored urine, a creatinine that has moved from 0.8 to 1.4 mg/dL over 48 hours, a potassium of 5.8 mEq/L, and severe unrelenting quadriceps pain does meet criteria and warrants immediate transfer.

The differential the sports RD must own has three columns. Column one is normal exercise-induced CK excursion: high CK, expected symptom pattern (delayed-onset muscle soreness that maps to the session), clear urine, stable renal function, stable electrolytes, and a downward CK trajectory on repeat draw. This is the vast majority of what the RD will see and does not require ED escalation. Column two is exertional rhabdomyolysis: high CK plus myoglobinuria, renal or electrolyte derangement, and out-of-proportion symptoms. This warrants immediate sports-medicine or ED referral, IV fluids, and a co-managed return-to-training plan. Column three is a rhabdomyolysis-adjacent presentation that does not yet meet full criteria but has one worrying element — a CK trajectory that is still climbing at 72 hours, mild renal signal, or a clinical picture that does not track the workout load. This warrants the sports-medicine consult, hydration protocol, and serial draws over 48-72 hours to see whether it self-resolves or crosses into full rhabdo.

The exertional rhabdo risk factors the intake should always screen for are: recent unaccustomed session, especially eccentric-heavy or hot-environment; recent sickle-cell trait relevant history; recent viral illness (which primes muscle for excessive breakdown); statin use or the recent addition of a statin; concurrent creatine, caffeine, or stimulant preload at unusually high doses; NSAID use in the peri-session window; and any past history of severe post-exercise pigmenturia or a personal or family history of an underlying metabolic myopathy (McArdle disease, carnitine palmitoyltransferase deficiency, malignant hyperthermia susceptibility). An athlete with a history of two or more prior episodes of exertional rhabdomyolysis at loads that would not be expected to produce it warrants a metabolic-myopathy workup regardless of the current draw.

The Weekly-Trending Protocol That Replaces the Single-Draw Misread

The single fix that solves the majority of CK misinterpretations in athletes is to stop treating CK as a snapshot and start treating it as a trend. The protocol the sports RD should run when a CK value surfaces in the intake or a mid-camp panel is a four-step trending sequence. Step one: get the session log for the 72 hours preceding the original draw. Note the eccentric load, the movement patterns, the total volume, and whether the session was accustomed or novel. Step two: repeat the CK draw 24 hours after the first, in the same lab if possible, with a paired basic metabolic panel and urinalysis. The second value tells you the direction. Step three: if the second draw is downtrending and the athlete is clinically well with normal renal function and clear urine, close the workup — this is a normal exercise-induced excursion, no restriction needed beyond the athlete's own recovery tolerance. Step four: if the second draw is flat or rising, or if any renal or urine finding has emerged, escalate to the team physician or sports-medicine consultant for a third draw and a co-managed decision on training modification.

The trending protocol also solves the reverse error, which is arguably more dangerous: the athlete whose single draw looks 'only mildly elevated' but whose CK is actually on the rising limb of a rhabdomyolysis trajectory that will peak two days later. A CK of 1,800 U/L that is on its way to 40,000 U/L, in an athlete with early tea-colored urine, is a very different picture than a CK of 1,800 U/L that peaked at 6,000 U/L yesterday and is coming down. The single draw does not distinguish them. The repeat draw does.

Reference-range documentation matters in the chart trail. The sports RD's SOAP note for a CK case should always cite the lab's ULN, the athlete's individual training-adjusted expected range if known, the time-since-session at the draw, the direction on repeat, the paired renal and urine findings, and the specific differential the RD ran through to arrive at the disposition. 'CK 4,820 U/L, day 2 post unaccustomed CrossFit AMRAP, dropped to 2,150 U/L at 22-hour repeat, creatinine stable at 0.8, urine clear, no myoglobinuria, no electrolyte derangement, athlete clinically well with expected DOMS pattern — normal exercise-induced excursion, no restriction, resume training as tolerated with modified eccentric volume for the next 7 days' is a defensible read. 'CK elevated, referred to ED' is not.

Nutrition and Hydration Levers Around a CK Case

The RD's operational levers in a CK case are hydration, carbohydrate availability, protein sufficiency, and — when co-managed with sports medicine — the timing of resumption of high-eccentric training. Hydration first: an athlete inside a large CK excursion should be maintained at a urine specific gravity of 1.020 or lower on serial checks until the CK has clearly turned downward, which usually means moving 3-5 L per day of fluid with electrolytes appropriate to sweat losses. This protects renal clearance of the myoglobin fraction that is spilling and reduces the probability that a borderline picture crosses into acute kidney injury. Overhydration to the point of hyponatremia is a separate risk to avoid; sodium-inclusive electrolyte fluids at 500-700 mg sodium per liter are the right instrument, not plain water.

Carbohydrate availability is the second lever. Under-fueled sessions produce disproportionately high muscle breakdown per unit of work, and the athlete recovering from a large CK excursion is not the athlete to run in a fasted or low-glycogen state. Restoring pre-session muscle glycogen with 5-7 g/kg per day of carbohydrate during the recovery window, and pre-loading 1-4 g/kg in the 1-4 hours before the next session, blunts the CK response of the subsequent session.

Protein sufficiency supports the membrane and cytoskeletal repair that follows the acute leak. The window here is not the immediate post-session shake; the window is the 24-72 hours after the demanding session, in which distributed protein intake of 0.4-0.5 g/kg per meal across four meals — landing near 1.6-2.2 g/kg per day total — supports the myofibrillar and membrane protein synthesis that closes the leak. Under-protein-ing the recovery window prolongs the CK excursion.

Return to eccentric loading is the co-managed decision that the RD should be part of but should not own alone. In an athlete whose CK has clearly downtrended, whose renal function is stable, and who is clinically well, a graded return to eccentric work at 40-60% of the previous session's volume is reasonable inside a week. In an athlete whose CK peaked at very high values (>25,000 U/L), or who had any renal or urine finding, the sports-medicine physician should be the one signing off on the return, and the RD's role is to document the nutrition-side inputs that support the co-managed plan.

The SOAP Pattern That Documents the Clearance Defensibly

The RD's SOAP note for a CK case is the artifact that protects the athlete and the RD both. Under Subjective, document the session that preceded the draw with enough specificity that a reader can tell whether the load was novel or accustomed, the athlete's symptom pattern with a pain-out-of-proportion screen, the urine appearance the athlete reports, and any red-flag history from the risk-factor screen above. Under Objective, document the CK value and its time-since-session, the paired renal function, urinalysis result, and electrolyte panel, and the trajectory on repeat draw. Under Assessment, name the differential explicitly — 'exercise-induced CK excursion,' 'exertional rhabdomyolysis,' or 'rhabdomyolysis-adjacent presentation warranting serial monitoring' — and justify the call against the criteria above. Under Plan, specify the hydration prescription with target urine specific gravity, the carbohydrate and protein targets for the recovery window, the training modification, the repeat-draw schedule if applicable, and the referral trigger for escalation.

The three co-management triggers to the sports-medicine physician are: any rhabdomyolysis-defining picture on the differential; any CK trajectory that has not clearly downtrended by 72 hours in the presence of clinical symptoms; and any athlete with a personal or family history of a metabolic myopathy or two or more prior unexplained episodes of exertional rhabdomyolysis. Everything else the RD can close in the intake with the trending protocol, the SOAP note, and a modified-eccentric-volume plan for the coming week.

The 24-year-old CrossFit athlete in the intake vignette above did not need an ED visit, a two-week training suspension, or the loss of her Saturday qualifier. She needed a repeat CK 24 hours after the first, paired with a renal and urine check, an assessment of trajectory, a hydration and carbohydrate prescription, and a modified eccentric-volume plan for the next week. The lab reference range that flagged her at 4,820 U/L was calibrated on a population she is not part of. The sports RD who reads CK through the athlete-adjusted frame — trajectory, panel, symptom cluster, and the exercise-induced excursion curve — is the difference between an athlete who competes on Saturday and an athlete who does not.

Ready to modernize your practice?

Calsanova gives dietitians AI-powered meal planning, food recognition, video consultations, and HIPAA-compliant infrastructure.

Start your free trial

Get more like this.

Evidence-based writing on nutrition, performance, and the research behind what actually works. No spam, no daily emails — just the good stuff.

Written by Nelson Marques, MS, RD, LD — a registered dietitian and performance nutrition specialist. Founder of Calsanova. More about Nelson

More from the Classroom

hs-CRP Interpretation in Athletes: Why the Cardiovascular-Risk Reference Range Misreads Training-Driven Elevations, the Ferritin and Iron-Status Cross-Talk the Intake Must Integrate, and the Post-Session Draw-Timing Correction That Separates the Real Cases

A 32-year-old marathon runner arrives at intake with an hs-CRP flagged at 4.8 mg/L on a routine cardiovascular-risk panel, a primary-care recommendation to begin statin therapy for 'elevated cardiovascular inflammation,' and a training week averaging 68 miles across 6 to 7 sessions with a 22-mile long run 36 hours before the draw. The standard hs-CRP interpretation was calibrated in the AHA/CDC cardiovascular-risk-stratification framework — below 1.0 mg/L low risk, 1.0 to 3.0 mg/L average risk, above 3.0 mg/L high risk — using populations dominated by metabolic-syndrome-associated inflammation, and it misclassifies a substantial fraction of the trained-endurance-athlete cases where the elevation is a training-load-driven acute-phase response that resolves off the training window. Reading hs-CRP in isolation misses this case. Here is the structured hs-CRP workup for the sports-nutrition intake: the six-dimension interpretive frame, the acute-vs-chronic draw-timing correction, the ferritin and iron-status cross-talk (hs-CRP is an acute-phase modifier of the iron read), the metabolic-syndrome and body-composition overlay, the four-quadrant clinical matrix, and the SOAP pattern that documents the case defensibly against the statin-referral read.

August 4, 2026

Uric Acid Interpretation in Athletes: Why the High-Protein and High-Fructose Sports-Nutrition Diet Confounds the Standard Read, the Renal-vs-Metabolic Differential, and the Purine-Load Audit the Intake Must Run

A 34-year-old ultramarathon runner arrives at intake with a serum uric acid of 8.9 mg/dL flagged as 'hyperuricemia' on a routine metabolic panel, a primary-care referral to a rheumatologist for suspected gout despite no joint symptoms, and a nutrition history dominated by a self-directed high-protein endurance diet, a race-week carbohydrate load leaning on fructose-rich sports drinks, and a training-day sweat rate the workup did not capture. The standard uric acid interpretation was calibrated against a sedentary reference population and misses the athletic case where the elevation runs through a purine-load overlay, a sweat-driven concentration artifact, a fructose-driven hepatic de novo synthesis pathway, and (in a subset of cases) a genuine renal or metabolic disorder the panel is finally surfacing. Reading uric acid in isolation misses this case. Here is the structured uric acid workup for the sports-nutrition intake: the five-dimension interpretive frame, the purine-load audit against the protein and organ-meat pattern, the fructose-load overlay that separates the sports-drink and race-week driver, the sweat-concentration correction the endurance intake must run, the four-quadrant clinical matrix, and the SOAP pattern that documents the case defensibly against the rheumatology referral.

July 16, 2026

Liver Enzyme Interpretation in Athletes: Why AST and ALT Rise With Training, GGT as the Alcohol vs Training vs Supplement Disambiguator, and the Hepatotoxic-Supplement Differential in the Sports Nutrition Intake

A 27-year-old CrossFit competitor arrives at intake with an AST of 78 U/L and ALT of 62 U/L flagged as 'abnormal' on a routine hepatic panel, a primary-care recommendation to abstain from alcohol despite a self-reported intake of one to two drinks per week, and a supplement stack he has not disclosed to his primary care physician. The standard hepatic panel was calibrated against a general-population reference distribution and reads skeletal-muscle-derived AST and ALT elevations as hepatic dysfunction, and the alcohol-first differential misses the case where the actual driver runs through an undisclosed SARM cycle, a high-dose green tea extract, or a multi-ingredient formulation. Reading AST and ALT in isolation misses this case. Here is the structured liver enzyme workup for the sports-nutrition intake: the six-dimension interpretive frame, the GGT differential that separates alcohol-driven from training-driven from supplement-driven elevation, the CK and AST-to-ALT ratio overlay that surfaces the skeletal-muscle contribution, the hepatotoxic-supplement inventory the intake must directly capture, the four-quadrant clinical matrix, and the SOAP pattern that documents the case defensibly.

July 14, 2026